Strengthening CNS oncology diagnostics at the heart of America’s largest medical ecosystem

CNSide Diagnostics, a subsidiary of Plus Therapeutics (NASDAQ: PSTV), has officially expanded into Levit Green, a premier life sciences innovation campus developed by Hines in Houston, one of the fastest-growing biomedical hubs in the United States.

Situated just steps from the Texas Medical Center, the world’s largest medical complex, this strategic move significantly enhances CNSide’s ability to accelerate the development and commercialization of cutting-edge CNS oncology diagnostics.

Why This Move Matters

The new CNSide and Plus Therapeutics headquarters at Levit Green provides unparalleled access to the resources, talent, and clinical collaborations needed to advance complex neurological cancer diagnostics and therapies.

The location offers:

• Advanced laboratory infrastructure to support high-throughput, high-precision testing
• Immediate access to world-class clinical and research institutions
• Proximity to leading oncology, neurology, and translational science programs
• A collaborative ecosystem built specifically for biotech and life sciences innovation

Together, these advantages create a powerful platform for accelerating discovery, validation, and clinical adoption of CNSide’s diagnostic technologies.

Advancing CNS Oncology Innovation

CNSide Diagnostics is focused on transforming how clinicians detect, monitor, and manage cancers of the central nervous system. By establishing operations at Levit Green, the company is positioned at the epicenter of scientific collaboration and medical innovation, enabling faster progress from research to real-world clinical impact.

This expansion also strengthens Plus Therapeutics’ broader mission to advance both CNS oncology diagnostics and targeted radiotherapeutics, creating a tightly integrated ecosystem for innovation in neuro-oncology care.

Strategic Growth for a Critical Mission

As the demand for precision diagnostics and advanced CNS cancer therapies continues to grow, the move to Levit Green represents a major milestone for both CNSide Diagnostics and Plus Therapeutics, reinforcing their commitment to building the infrastructure, partnerships, and scientific leadership required to deliver next-generation patient care.

Learn More

Read the full article: https://lnkd.in/g5p-9R9Z

About CNSide Diagnostics

CNSide Diagnostics is a molecular diagnostics company dedicated to advancing precision diagnostics for cancers of the central nervous system, enabling earlier detection, better disease monitoring, and more informed treatment decisions.

#CNSideDiagnostics #CNSide #PlusTherapeutics #PSTV #LevitGreen #TexasMedicalCenter #NeuroOncology #PrecisionDiagnostics #BiotechInnovation #LifeSciences #CNSOncology #Radiotherapy #CancerDiagnostics #HoustonBiotech